- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04166903
Prospective Follow-up, Marathon, Long Term, Inflammation and Cardiovascular System (Pro-MagIC)
Prospective Long Term Follow-up Analysis of Exercise-induced Physiological Changes in Male Runners
Study Overview
Status
Conditions
Detailed Description
Physical activity is associated with health benefits. Acute prolonged and strenuous exercise, i.e. Marathon running, leads to hemodynamic, endothelial and myocardial functional changes. Whether these myocardial, endothelial and hemodynamic changes can also develop and persist through repetitive extreme and prolonged physical activity is currently still a matter of controversy. In addition, it is not known whether adaptations and changes over time can develop into clinically relevant cardiovascular events with negative health consequences in healthy athletes. The aim of this study is to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years.
For this purpose, 277 male participants from the Be-MaGIC study (Marathon 2009) are examined in this prospective observational study. A single examination with the following components will take place: Anthropometry, clinical examination, laboratory, resting / exercise electrocardiography cardiopulmonary stress test, echocardiography, and fundus camera. Further examinations will be conducted in participants with abnormal examination results in line with current clinical recommendations.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Michael Schindler, MD
- Phone Number: +49 (0) 89 289 24441
- Email: Michael.Schindler@mri.tum.de
Study Contact Backup
- Name: Julia Schoenfeld, MSc.
- Phone Number: +49 (0)89 289 24517
- Email: Julia.Schoenfeld2@mri.tum.de
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 80992
- Recruiting
- Department of Prevention, Rehabilitation and Sports Medicine, Munich, Germany
-
Contact:
- Michael Schindler, MD
- Email: Michael.schindler@mri.tum.de
-
Contact:
- Julia Schoenfeld, MSc.
- Email: Julia.schoenfeld2@mri.tum.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Declaration of consent Participants must have participated in the Be-MaGIC study in 2009
- current age: 30 - 70 years
- sex: male
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes of right ventricular systolic function (RV-EF)
Time Frame: 10 years
|
Echocardiography
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in left ventricular ejection fraction (LV-EF)
Time Frame: 10 years
|
Echocardiography
|
10 years
|
Changes in left ventricular diastolic function (E/e´)
Time Frame: 10 years
|
Echocardiography
|
10 years
|
Change in cardiac markers (e.g. cardiac Troponin)
Time Frame: 10 years
|
Clinical chemistry (blood samples)
|
10 years
|
Change in inflammation markers (e.g. C-reactive Protein)
Time Frame: 10 years
|
Clinical chemistry (blood samples)
|
10 years
|
Change in microcirculation (e.g. arteriolar-to-venular ratio)
Time Frame: 10 years
|
Static Retinal Vessel Analyzer
|
10 years
|
Change in macrocirculation (e.g. Intima media thickness)
Time Frame: 10 years
|
Carotid sonography
|
10 years
|
Change of prevalence of cardiovascular diseases
Time Frame: 10 years
|
Questionnaire
|
10 years
|
Association between changes of aforementioned parameters (see Topics 1-8) and potential underlying causes (e.g. sports history like number of ultraendurance competitions) in the examined cohort
Time Frame: 10 years
|
10 years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Michael Schindler, MD, Department of Prevention, Rehabilitation and Sports Medicine, Munich, Germany
- Principal Investigator: Johannes Scherr, MD, University Hospital Balgrist, University Zurich, Switzerland
- Study Director: Martin Halle, MD, Department of Prevention, Rehabilitation and Sports Medicine, Munich, Germany
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ProMagIC-Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Participants of the Be-MaGIC-Study 2009
-
Istinye UniversityCompletedThe Study Will Not be Based on Any Disease | Ability to Swim 100m Independent Freestyle | Be Between the Ages of 9-16 | Continuing Running as Part of a Sports ClubTurkey
-
University of PrimorskaS2P, Science to Practice, Ltd.; Motus Melior, Ltd.CompletedOnly Healthy Participants Are Included in the StudySlovenia
-
Ain Shams UniversityActive, not recruitingNumerical Rating Pain Score | the Total Doses of Pethidine Needed Through-out Delivery Will be Measured | the Incidence of Failed Delivery and Need of Cesarean Section Will be Assessed | the Incidence of Transient Fetal Bradycardia or Deceleration After the Administration of the Block... and other conditionsEgypt
-
PuratosUniversidad de GranadaCompleted
-
Provascular GmbHCompletedEfficacy of the Study DeviceGermany
-
University of AberdeenLipton Teas and InfusionsRecruitingThe Focus of the Study is Healthy VolunteersUnited Kingdom
-
Oslo Metropolitan UniversityUniversity of Oslo; The Research Council of Norway; Maastricht UniversityNot yet recruitingThe Focus of the Study is Shift Work
-
The Cleveland ClinicCompletedNo Condition is the Focus of the StudyUnited States
-
National Taiwan University HospitalCompletedThe Apparatus for Processing the Tubular Graft Modification Will be Designed and Evaluated. | The On-site Capturing of the Endothelial (Progenitor) Cells by Peptide-mediated Selective Adhesion in Vitro and in Vivo Will Also be Elucidated. | The Patency Rate of ITRI-made Artificial...Taiwan
-
Universidad Autonoma de Ciudad JuarezNot yet recruitingReduction in Mental Health and Suicide Are the Focus of Interest | Four Assessment Time Points Would be Used to Monitor Participants Through a Laid Down ConditionsMexico